These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 19166438)

  • 1. Inequalities in socio-economic status and invasive procedures for coronary heart disease: a comparison between the USA and the UK.
    Quatromoni J; Jones R
    Int J Clin Pract; 2008 Dec; 62(12):1910-9. PubMed ID: 19166438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Socioeconomic inequalities in access to treatment for coronary heart disease: A systematic review.
    Schröder SL; Richter M; Schröder J; Frantz S; Fink A
    Int J Cardiol; 2016 Sep; 219():70-8. PubMed ID: 27288969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inequality in access to coronary revascularization in Sweden.
    Haglund B; Köster M; Nilsson T; Rosén M
    Scand Cardiovasc J; 2004 Dec; 38(6):334-9. PubMed ID: 15804798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Universal health insurance coverage does not eliminate inequities in access to cardiac procedures after acute myocardial infarction.
    Pilote L; Joseph L; Bélisle P; Penrod J
    Am Heart J; 2003 Dec; 146(6):1030-7. PubMed ID: 14660995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of socioeconomic status on clinical outcomes and quality of life after percutaneous coronary intervention.
    Denvir MA; Lee AJ; Rysdale J; Walker A; Eteiba H; Starkey IR; Pell JP
    J Epidemiol Community Health; 2006 Dec; 60(12):1085-8. PubMed ID: 17108307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Socioeconomic differences in the pathways to diagnosis of coronary heart disease: a qualitative study.
    Schröder SL; Fink A; Hoffmann L; Schumann N; Martin O; Frantz S; Richter M
    Eur J Public Health; 2017 Dec; 27(6):1055-1060. PubMed ID: 29096003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association between socioeconomic status of high-risk patients with coronary heart disease and the treatment rates of evidence-based medicine for coronary heart disease secondary prevention in China: Results from the Bridging the Gap on CHD Secondary Prevention in China (BRIG) Project.
    Niu S; Zhao D; Zhu J; Liu J; Liu Q; Liu J; Wang W; Smith SC;
    Am Heart J; 2009 Apr; 157(4):709-15.e1. PubMed ID: 19332200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical costs and quality of life 10 to 12 years after randomization to angioplasty or bypass surgery for multivessel coronary artery disease.
    Hlatky MA; Boothroyd DB; Melsop KA; Brooks MM; Mark DB; Pitt B; Reeder GS; Rogers WJ; Ryan TJ; Whitlow PL; Wiens RD
    Circulation; 2004 Oct; 110(14):1960-6. PubMed ID: 15451795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inequalities in access to coronary angiography and revascularisation: the association of deprivation and location of primary care services.
    Hippisley-Cox J; Pringle M
    Br J Gen Pract; 2000 Jun; 50(455):449-54. PubMed ID: 10962781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of minimally invasive coronary bypass and percutaneous transluminal coronary angioplasty in the treatment of double-vessel coronary disease: Two-year follow-up of a new hybrid procedure compared with "on-pump" double bypass grafting.
    de Cannière D; Jansens JL; Goldschmidt-Clermont P; Barvais L; Decroly P; Stoupel E
    Am Heart J; 2001 Oct; 142(4):563-70. PubMed ID: 11579343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Equity in Canadian health care: does socioeconomic status affect waiting times for elective surgery?
    Shortt SE; Shaw RA
    CMAJ; 2003 Feb; 168(4):413-6. PubMed ID: 12591780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender and age inequity in the provision of coronary revascularisation in England in the 1990s: is it getting better?
    Shaw M; Maxwell R; Rees K; Ho D; Oliver S; Ben-Shlomo Y; Ebrahim S
    Soc Sci Med; 2004 Dec; 59(12):2499-507. PubMed ID: 15474204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Socioeconomic inequalities in health. No easy solution.
    Adler NE; Boyce WT; Chesney MA; Folkman S; Syme SL
    JAMA; 1993 Jun 23-30; 269(24):3140-5. PubMed ID: 8505817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What is the impact of socio-economic inequalities on the use of mental health services?
    Amaddeo F; Jones J
    Epidemiol Psichiatr Soc; 2007; 16(1):16-9. PubMed ID: 17427600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary revascularisation: why do rates vary geographically in the UK?
    Black N; Langham S; Petticrew M
    J Epidemiol Community Health; 1995 Aug; 49(4):408-12. PubMed ID: 7650465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Five-year clinical and functional outcome comparing bypass surgery and angioplasty in patients with multivessel coronary disease. A multicenter randomized trial. Writing Group for the Bypass Angioplasty Revascularization Investigation (BARI) Investigators.
    JAMA; 1997 Mar; 277(9):715-21. PubMed ID: 9042843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. International comparison of waiting times for selected cardiovascular procedures.
    Carroll RJ; Horn SD; Soderfeldt B; James BC; Malmberg L
    J Am Coll Cardiol; 1995 Mar; 25(3):557-63. PubMed ID: 7860896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An audit on access to coronary artery surgery within a health district using New Zealand priority criteria as a benchmark.
    Leung WC; Tregoning D; Farrer M
    Public Health; 1999 Jan; 113(1):13-7. PubMed ID: 10823743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short- and long-term health related quality-of-life and anginal status of the Arterial Revascularisation Therapies Study part II, ARTS-II; sirolimus-eluting stents for the treatment of patients with multivessel coronary artery disease.
    van Domburg RT; Daemen J; Morice MC; de Bruyne B; Colombo A; Macaya C; Richardt G; Fajadet J; Hamm C; van Es GA; Wittebols K; Macours N; Stoll HP; Serruys PW
    EuroIntervention; 2010 Apr; 5(8):962-7. PubMed ID: 20542782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term clinical and economic analysis of the Endeavor zotarolimus-eluting stent versus the cypher sirolimus-eluting stent: 3-year results from the ENDEAVOR III trial (Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions).
    Eisenstein EL; Leon MB; Kandzari DE; Mauri L; Edwards R; Kong DF; Cowper PA; Anstrom KJ;
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1199-207. PubMed ID: 20129546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.